Literature DB >> 32410142

Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment.

Yehia Saleh1, Ola Abdelkarim2, Khader Herzallah1, George S Abela3.   

Abstract

Anthracycline is a mainstay in treatment of many cancers including lymphoma and breast cancer among many others. However, anthracycline treatment can be cardiotoxic. Although anthracycline-induced cardiotoxicity is dose dependent, it can also occur early at the onset of treatment and even up to several years following completion of treatment. This review article focuses on the understanding of mechanisms of anthracycline-induced cardiotoxicity, the treatments, and recommended follow-up and preventive approaches.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Anthracyclines; Cardio-oncology; Heart failure; Prevention

Mesh：

Substances：

Year:  2021        PMID： 32410142     DOI： 10.1007/s10741-020-09968-2

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  84 in total

Review 1.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

2.  A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.

Authors:  Husam Abdel-Qadir; Peter C Austin; Douglas S Lee; Eitan Amir; Jack V Tu; Paaladinesh Thavendiranathan; Kinwah Fung; Geoffrey M Anderson
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676

3.  Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giulia Bacchiani; Ines Tedeschi; Carlo A Meroni; Fabrizio Veglia; Maurizio Civelli; Giuseppina Lamantia; Nicola Colombo; Giuseppe Curigliano; Cesare Fiorentini; Carlo M Cipolla
Journal:  Circulation       Date:  2015-05-06       Impact factor: 29.690

Review 4.  Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.

Authors:  Peter A Henriksen
Journal:  Heart       Date:  2017-12-07       Impact factor: 5.994

5.  Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes.

Authors:  Chee Chew Lim; Christian Zuppinger; Xinxin Guo; Gabriela M Kuster; Michiel Helmes; Hans M Eppenberger; Thomas M Suter; Ronglih Liao; Douglas B Sawyer
Journal:  J Biol Chem       Date:  2003-12-14       Impact factor: 5.157

6.  Molecular mechanisms of anthracycline activity.

Authors:  Giovanni Luca Beretta; Franco Zunino
Journal:  Top Curr Chem       Date:  2008

7.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

Authors:  K M Tewey; T C Rowe; L Yang; B D Halligan; L F Liu
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

8.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity.

Authors:  Sui Zhang; Xiaobing Liu; Tasneem Bawa-Khalfe; Long-Sheng Lu; Yi Lisa Lyu; Leroy F Liu; Edward T H Yeh
Journal:  Nat Med       Date:  2012-10-28       Impact factor: 53.440

9.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

10.  Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?

Authors:  Daniel Bernstein
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367
View more
  14 in total

Review 1.  The role of cellular senescence in cardiac disease: basic biology and clinical relevance.

Authors:  Mozhdeh Mehdizadeh; Martin Aguilar; Eric Thorin; Gerardo Ferbeyre; Stanley Nattel
Journal:  Nat Rev Cardiol       Date:  2021-10-19       Impact factor: 32.419

Review 2.  Atrial Fibrillation and Cancer Patients: Mechanisms and Management.

Authors:  David L Madnick; Michael G Fradley
Journal:  Curr Cardiol Rep       Date:  2022-08-17       Impact factor: 3.955

Review 3.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

4.  A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.

Authors:  Ana de la Fuente; Marta Santisteban; Josep Lupón; José Manuel Aramendía; Agnes Díaz; Ana Santaballa; Amparo Hernándiz; Pilar Sepúlveda; Germán Cediel; Begoña López; José María López Picazo; Manuel M Mazo; Gregorio Rábago; Juan José Gavira; Ignacio García-Bolao; Javier Díez; Arantxa González; Antoni Bayés-Genís; Susana Ravassa
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

5.  Mitochondrial shaping proteins as novel treatment targets for cardiomyopathies.

Authors:  Siavash Beikoghli Kalkhoran; Sauri Hernandez-Resendiz; Sang-Ging Ong; Chrishan J A Ramachandra; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-08

Review 6.  Role of Oxidative Stress in the Mechanisms of Anthracycline-Induced Cardiotoxicity: Effects of Preventive Strategies.

Authors:  Rodrigo Carrasco; Rodrigo L Castillo; Juan G Gormaz; Montserrat Carrillo; Paaladinesh Thavendiranathan
Journal:  Oxid Med Cell Longev       Date:  2021-01-25       Impact factor: 6.543

7.  Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress.

Authors:  Akheruz Zaman Ahmed; Shakta Mani Satyam; Prakashchandra Shetty; Melanie Rose D'Souza
Journal:  Scientifica (Cairo)       Date:  2021-01-13

Review 8.  Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research.

Authors:  Jean C Bikomeye; Andreas M Beyer; Jamila L Kwarteng; Kirsten M M Beyer
Journal:  Int J Environ Res Public Health       Date:  2022-02-19       Impact factor: 3.390

Review 9.  Efficacy of Chinese Medicine Injection for Cardiotoxic Injury of Anthracycline Chemotherapy Drugs: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Mingxuan Li; Hongdian Li; Hongxu Liu; Xiaolei Lai; Wenlong Xing
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

Review 10.  Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity.

Authors:  Yonghe Ding; Ke Du; Yu-Juan Niu; Yong Wang; Xiaolei Xu
Journal:  Oxid Med Cell Longev       Date:  2022-08-03       Impact factor: 7.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.